RESULT OF VOTING AT THE GENERAL MEETING OF
RECKITT BENCKISER GROUP PLC
HELD ON 27 JANUARY 2026
The resolutions proposed at the General Meeting of Reckitt Benckiser Group plc (the "Company") were passed by the requisite majority by poll. The results are set out below:
STATEMENT OF POLL
|
RESOLUTION |
VOTES FOR |
% |
VOTES AGAINST |
% |
VOTES CAST |
% of ISC Voted |
VOTES WITHHELD |
|
1. To declare a special dividend of 235 pence per Existing Ordinary Share |
528,337,541 |
99.99% |
53,544 |
0.01% |
528,391,085 |
78.66% |
287,362 |
|
2. To approve the Share Consolidation |
528,117,554 |
99.96% |
223,895 |
0.04% |
528,341,449 |
78.65% |
336,998 |
|
3. To renew the Directors' authority to allot shares |
486,110,533 |
92.01% |
42,186,892 |
7.99% |
528,297,425 |
78.65% |
381,022 |
|
4. To renew the Directors' power to disapply pre-emption rights in respect of up to 5% of issued share capital |
524,709,308 |
99.36% |
3,361,977 |
0.64% |
528,071,285 |
78.61% |
607,162 |
|
5. To renew the Directors' power to disapply pre-emption rights in respect of up to an additional 5% of issued share capital |
522,167,204 |
98.89% |
5,883,681 |
1.11% |
528,050,885 |
78.61% |
627,922 |
|
6. To renew the Company's authority to purchase its own shares |
526,959,800 |
99.86% |
764,017 |
0.14% |
527,723,817 |
78.56% |
954,270 |
Resolutions 4 to 6 are special resolutions.
A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes for or against a resolution.
Full text of the resolutions is set out in the Notice of General Meeting which forms part of the Circular dated 7 January 2026. Capitalised terms used but not otherwise defined in this announcement have the same meaning given to them in the Circular dated 7 January 2026.
A copy of the above results will shortly be available on the Company's website at www.reckitt.com.
In accordance with UK Listing Rule 6.4.2 a copy of all the resolutions passed have been submitted to the National Storage Mechanism and in due course will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
As at the close of business on 26 January 2026, the issued share capital of the Company consisted of 702,089,325 ordinary shares of 10 pence each, 30,355,264 of which were held as treasury shares. Therefore, the total voting rights in the Company as at that time were 671,734,061.
Listing and Trading Application
Application has been made to the Official List of the Financial Conduct Authority and to trade on the London Stock Exchange's main market for listed securities for a total of 674,005,752 new ordinary shares 10⁵⁄₁₂ pence each to be admitted.
For further Information
Catheryn O'Rourke
Company Secretary
Tel. 01753 217 800
103-105 Bath Road, Slough SL1 3UH
Registered in England and Wales, No. 6270876
About Reckitt
We make the products people trust to care for the ones they love. We are home to some of the world's best-loved consumer health and hygiene brands, including Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen, Strepsils, Vanish and Veet. Consumers are at the heart of everything we do. By creating innovative, science-backed solutions, we support people every day to live healthier lives.
Reckitt exists to protect, heal and nurture in the pursuit of a cleaner, healthier world. This commitment goes beyond the products we make. Through our actions, we expand access to healthcare, education and economic opportunities. We support the planet by reducing waste, conserving resources and driving sustainable innovation.
We believe good health starts at home. With every action we take, we strive to make our consumers' lives easier, cleaner and healthier, to strengthen communities and to create a more sustainable future.
*Reckitt is the trading name of the Reckitt group of companies
Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
